Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences Outlicenses Proteins for Lung Cancer Dx; Increasing TMT to 12- and 18-Plex

NEW YORK (GenomeWeb News) - UK cancer detection firm Oncimmune will develop a diagnostic test for lung cancer using Proteome Sciences’ patents covering the Annexin I and Annexin 2 proteins under a non-exclusive licensing agreement announced by the two firms this week.
 
A test is expected to hit the market during the first half of the year, Proteome Sciences said in a statement. It will receive royalty payments from product sales under the agreement.
 
Further terms of the deal were not disclosed.
 
Proteome Sciences received US patent number 6,645,465 covering the Annexin proteins and antibodies in late 2003. The proteins have a putative role in controlling cell signaling and metabolism and have been associated with various diseases.
 
The company also said this week that it has increased the plexing rates for its TMT isobaric mass tags. Currently available in single, two-, and six-plex, it will become available in 12- and 18-plex some time this year, Proteome Sciences said.
 
The TMT technology, which is offered by Thermo Fisher Scientific under a licensing agreement, pertains to a method for labeling analytes in multiplex fashion in a mass spectrometer.
 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.